Dementia Risk In Old Age Linked To Belly Size In Midlife |
Dementia Risk In Old Age Linked To Belly Size In MidlifeA new study by researchers from the US and Sweden showed that having a large belly in midlife increased the risk of having dementia in old age, with overweight and obese people with large bellies having double or triple risk. In other words, while being overweight and obese was a risk factor, study showed this was significantly affected by where weight was carried in midlife. The study is published in the online issue of journal Neurology , and was conducted by Dr Rachel Whitmer, who is a research scientist at Kaiser Permanente Division of Research in Oakland, California, and colleagues. Previous research has linked waist circumference or central obesity and body mass index ( BMI ) in elderly people to risk of developing dementia, and it has also shown that having a large abdomen in midlife is linked to higher risk of heart disease, stroke and diabetes. But this is the first study to show a link between belly fat in midlife and risk of developing dementia decades later. Whitmer and colleagues studied 6, 583 health plan members of Kaiser Permanente living in Northern California who had had their sagittal abdominal diameter ( SAD ) measured between 1964 and 1973 when they were aged between 40 and 45. SAD, which is a measure of belly density, is taken using a caliper that measures distance from back to upper abdomen, when positioned midway between top of pelvis and bottom of ribcage. The researchers explained that the size of belly at this point is an indicator of amount of fat tissue that's wrapped around organs in abdomen. By examing medical records between 1994 and 2006, the researchers established that 16 per cent ( 1, 049 ) of participants had dementia an average of 36 years later. Using statistical techniques and adjusting for age, sex, race, education, blood pressure, stroke, and other medical and demographic variables, they examined links between midlife SAD and dementia incidence. The results showed that:
" Central obesity in midlife increases risk of dementia independent of diabetes and cardiovascular comorbidities. Fifty percent of adults have central obesity; therefore, mechanisms linking central obesity to dementia need to be unveiled. ' Whitmer suggested that measuring midlife belly size may be a better indicator of long term disruption of metabolism that leads to dementia than using abdominal size in older people because as people age they lose muscle and bone mass and their belly becomes proportionally larger. She said this was a disturbing finding, considering that 50 per cent of adult Americans have abdominal obesity. " It is well known that being overweight in midlife and beyond increases risk factors for disease, " said Whitmer. " However, where one carries the weight, especially in midlife, appears to be an important predictor for dementia risk, " she added. Changes in the brain that lead to Alzheimer's can start in young to middle adulthood, as autopsies have revealed, explained Whitmer. Research has also shown that high abdominal fat in older people is linked to higher rate of brain atrophy. However, Whitmer said that: " These findings imply that dangerous effects of abdominal obesity on brain may start long before signs of dementia appear. " However, researchers also cautioned that, as with all observational studies, we can't say these results show that belly size drives dementia risk, more likely explanation is that it's one of a complex set of inter-related health factors and behaviours. The researchers called for further studies to investigate underlying mechanisms that link belly size in midlife to risk of developing dementia later. Dementia isn't a specific disease, it is an umbrella term for a group of symptoms caused by a range of brain disorders that prevents people getting on with everyday life such as eating and getting dressed or going shopping. It impairs memory, language, ability to solve problems, and control emotions, and can change a person's personality or make them anxious or see things that are not there. Alzheimer's disease and stroke are two examples of diseases that can cause dementia. Drugs can slow or improve some of symptoms but there's no cure. 'Central obesity and increased risk of dementia more than three decades later. ' Whitmer, R. A. , Gustafson, D. R. , Barrett-Connor, E. , Haan, M. N. , Gunderson, E. P. , Yaffe, K. Neurology , Published online before print March 26, 2008. DOI: 10. 1212/01. wnl. 0000306313. 89165. ef Click here for Abstract. Sources: journal abstract, PR Newswire press release, Medline Plus Written by: Catharine Paddock, PhD Copyright: Medical News Today Not to be reproduced without permission of Medical News Today
Looking for beauty. That's here. |
What we know about Tramadol.uses of Tramadol Tramadol is used to relieve ongoing, moderate pain in people who need all-day pain relief ( " around the clock " dosing ) . It's similar to narcotic pain medications. It works on certain nerves in brain that control how you experience pain. how to use of Tramadol Take Tramadol by mouth, either always with food or always without food, usually once daily or as directed by your doctor. If nausea occurs, consult your doctor or pharmacist about ways to decrease it ( e. g. , antihistamines, lying down for 1 to 2 hours with as little head movement as possible ) . side effects of Tramadol Nausea, vomiting, constipation, lightheadedness, dizziness, drowsiness, headache, or weakness may occur while use Tramadol. If any of these effects persist or worsen, tell your doctor or pharmacist promptly. precautions of Tramadol Before taking long-acting Tramadol, tell your doctor or pharmacist if we are allergic to it; or to other narcotics ( e. g. , codeine ) ; or if we have any other allergies. interactions of Tramadol Your doctor or pharmacist may already be aware of any possible drug interactions and may be monitoring we for them. Do not start, stop, or change dosage of any medicine before checking with them first. FDA approved Tramadol |
Beware of Online Cancer Fraud. FDA and the Federal Trade Commission have launched a program targeting online health fraud that takes advantage of people with cancer. Protect yourself with this advice. Prilosec and Nexium: No Increased Risk of Heart Problems Found. After a comprehensive, scientific review, FDA has determined that Prilosec (omeprazole) and Nexium (esomeprazole) are not likely to be associated with an increased risk of heart problems Warning Required for Nonoxynol 9 Over-the-Counter Contraceptives. Over-the-counter, stand-alone vaginal contraceptive and spermicidal products containing the chemical ingredient nonoxynol 9 (N9) must now include a warning that the chemical does not protect against infection from HIV or other sexually transmitted diseases Use Eye Cosmetics Safely. April is Women's Eye Health and Safety Month. Here are tips from FDA about storing, applying, wearing, and removing eye cosmetics. Civil Penalties Sought Against Maker of Hearing Aid. A hearing aid manufacturer breaks the law, and FDA is seeking more than $2 million in penalties Thyroid Medications: Q and A with Mary Parks, M.D.. January is Thyroid Awareness Month. Learn about thyroid medications from Mary Parks, M.D., Director of FDA's Division of Metabolic and Endocrine Drug Products. |
Dementia Risk In Old Age Linked To Belly Size In Midlife What we know about Tramadol. FDA approved Tramadol Beware of Online Cancer Fraud. FDA and the Federal Trade Commission have launched a program targeting online health fraud that takes advantage of people with cancer. Protect yourself with this advice. Looking for beauty. That's here. |